Friends for Life Orlando 2022 Sponsors
Diamond Level Sponsor
In 1923, the founders of Novo Nordisk began a journey to change diabetes. Today, we are thousands of employees across the world with the passion, the skills and the commitment to continue this journey to prevent, treat and ultimately cure diabetes. Novo Nordisk is proud to once again be a Platinum Level Sponsor of the Friends for Life conference, supporting the Family and Friends Banquet and Sports Central. Please come see us at the exhibition to learn more about our type 1 support program, our new camp program and be among the first to learn about the first and only durable insulin pen with 0.5 unit doing and memory function – NovoPen Echo®. To learn more about Novo Nordisk and our support to the type 1 diabetes community visit us at www.novonordisk-us.com.
Platinum Level Sponsors
Dexcom, Inc., headquartered in San Diego, CA, is dedicated to developing innovative glucose sensing technology and products to help patients and healthcare providers better manage diabetes. The Dexcom G6™ Continuous Glucose Monitoring (CGM) System does not require fingersticks for calibration or diabetes treatment decisions* and features simple, one-touch sensor insertion. The System provides exceptional accuracy with an overall MARD of 9.0%† and features an Urgent Low Soon alert that can warn users 20 minutes in advance of severe hypoglycemia (55 mg/dL). Dexcom is the only provider of CGM systems indicated for children ages 2 years and older. Please visit www.dexcom.com.
*If your glucose alerts and readings from the G6 do not match symptoms or expectations, use a blood glucose meter to make diabetes treatment decisions.
†MARD is a statistical measure of accuracy; the lower the number, the better.
Insulet Corporation (NASDAQ: PODD), headquartered in Massachusetts, is an innovative medical device company dedicated to making the lives of people with diabetes and other conditions easier through the use of its Omnipod® product platform. The Omnipod® Insulin Management System provides a unique alternative to traditional insulin delivery methods. With its simple, wearable design, the disposable Pod provides up to three days of non-stop insulin delivery, without the need to see or handle a needle. Insulet also leverages the unique design of its Pod, by tailoring its Omnipod® technology platform for the delivery of non-insulin subcutaneous drugs across multiple therapeutic areas. Founded in 2000, more than 140,000 users across the globe rely on Insulet’s Omnipod® Insulin Management System to bring simplicity and freedom to their lives. For more information, visit www.myomnipod.com.
Gold Level Sponsors
Abbott, the worldwide leader in continuous glucose monitoring (CGM), is committed to improving the lives of people with diabetes. The company manufactures, distributes, and markets innovative glucose monitoring systems and other valuable services to help patients and healthcare professionals better manage diabetes care needs. Abbott is pleased to be a sponsor of Friends for Life Orlando Conference. Connect with us at https://freestyle.abbott/cwd, on Facebook at @FreeStyleUS on Instagram at @FreeStyleDiabetes, and on Twitter @FreeStyleDiabet.
Tandem Diabetes Care, Inc. is a medical device company dedicated to improving the lives of people with diabetes through relentless innovation and revolutionary customer experience. The Company takes an innovative, user-centric approach to the design, development and commercialization of products for people with diabetes who use insulin. Tandem manufactures and sells the t:slim X2 insulin pump with Control-IQ technology. The t:slim X2 pump is capable of remote feature updates using a personal computer. Tandem is based in San Diego, California.
RX ONLY. The t:slim X2 insulin pump, Basal-IQ technology, and Control-IQ technology are intended for single patient use. The t:slim X2 pump, Basal-IQ technology, and Control-IQ technology are indicated for use with NovoLog or Humalog U-100 insulin.
Silver Level Sponsors
Every day more than 4,000 people are newly diagnosed with diabetes in America. Nearly 115 million Americans have diabetes or prediabetes and are striving to manage their lives while living with the disease. The American Diabetes Association (ADA) is the nation’s leading voluntary health organization fighting to bend the curve on the diabetes epidemic and help people living with diabetes thrive. For nearly 80 years the ADA has been driving discovery and research to treat, manage and prevent diabetes, while working relentlessly for a cure. We help people with diabetes thrive by fighting for their rights and developing programs, advocacy and education designed to improve their quality of life. Diabetes has brought us together. What we do next will make us Connected for Life. To learn more or to get involved, visit us at diabetes.org or call 1-800-DIABETES (1-800-342-2383). Information is available in English and Spanish. Join the fight with us on Facebook (American Diabetes Association), Twitter (@AmDiabetesAssn) and Instagram (@AmDiabetesAssn).
Medtronic is working together with the global community to change the way people manage diabetes. The company aims to transform diabetes care by expanding access, integrating care, and improving outcomes, so people living with diabetes can enjoy greater freedom and better health.
VIATRIS is a new kind of healthcare company, committed to providing access to medicines, advancing sustainable operations and developing innovative solutions. Formed in 2020 through the combination of Mylan and Upjohn, Viatris brings together manufacturing and distribution expertise with proven regulatory, medical and commercial capabilities.
*Page intended for U.S. Healthcare Providers.
Bronze Level Sponsors
Lilly has been a global leader in diabetes care since 1923, when we introduced the world’s first commercial insulin. Today we are building upon this heritage by working to meet the diverse needs of people with diabetes and those who care for them. Through research, collaboration and quality manufacturing we strive to make life better for people affected by diabetes and related conditions. We work to deliver breakthrough outcomes through innovative solutions—from medicines and technologies to support programs and more.
Xeris Pharmaceuticals, Inc., headquartered in Chicago, IL, is dedicated to unlocking the potential of glucagon. The company believes that easier-to-use medicines can have a profound impact on the lives of patients and their families. That’s why they are studying ready-to-use liquid glucagon, but that’s just the beginning. Thet are also studying how their formulation technology can impact patients with other conditions. Xeris has a persistent drive to pursue advancement that have the potential to change lives – get to know them and see how their technology is unlocking the potential of today’s medicines at www.xerispharma.com.
Friends of CWD
Beta Bionics is a public benefit corporation and certified B corp. committed to commercializing the iLet® bionic pancreas. We’re a people-focused company, here to serve the wider diabetes community. We want to make a difference and aim to improve the lives of people living with diabetes and hope to reduce the data and decision-making overload that PWD and their caregivers often deal with. To learn more about Beta Bionics, our team and our mission visit us at www.betabionics.com and @BetaBionics on social media.
The Certification Board for Diabetes Care and Education (CBDCE) is a not for profit certifying body that recognizes a number of different health professionals in the United States as having specialized knowledge about diabetes care and education. The organization name and certification designation underwent a change in 2020; you might be more familiar with the National Certification Board for Diabetes Educators or NCBDE and the Certified Diabetes Educator or CDE certification designation. The organization has been around since 1986, and the Certified Diabetes Care and Education Specialist or CDCES credential is seen as the gold standard in the diabetes world. Currently, over 19,900 health professionals hold the CDCES credential. CDCESs are committed and passionate about what the work they do in partnership with people with diabetes and their families and caregivers.
Diabeloop gathers the personality, passion, and skills of over 100 talented individuals, many of whom are personally touched by insulin-dependent diabetes. Founded in Grenoble, France in 2015, Diabeloop is a high-growth company that is developing AI-based, personalized solutions to improve clinical outcomes for people with diabetes while relieving their constant mental burden.
The JDRF – Beyond Type 1 Alliance provides greater support for those impacted by type 1 diabetes by tapping into the combined power of JDRF, the leading global organization funding T1D research, and Beyond Type 1, the organization with the largest online community of any diabetes nonprofit. The work of the Alliance centers around three core pillars: community programs, advocacy, and communications + education.
INHALE-1 (NCT04974528) is a research study that aims to look at how safe an inhaled insulin product is and how well it works in children and teenagers with diabetes. The study involves clinic visits, blood draws, and lung function tests. Qualified participants will either take inhaled insulin for 12 months or continue mealtime injectable insulin for 6 months and then switch to inhaled insulin for 6 months. Inhaled insulin will be provided at no cost. Participants will be asked to check their glucose level frequently using a study provided continuous glucose monitor (CGM). Compensation will be available for time and travel and a CGM will be provided throughout the study.
The study is open to children and teenagers between ages 4-17 diagnosed with type 1 or type 2 diabetes and using mealtime insulin with an A1c between 7-11%. Visit INHALE-1 for more information on eligibility and how to enroll.
Provention Bio, Inc. (Nasdaq: PRVB) is a biopharmaceutical company focused on advancing the development of investigational therapies that may intercept and prevent debilitating and life-threatening immune-mediated disease. The Company’s pipeline includes a late-stage product candidate for type 1 diabetes (T1D) as well as clinical drug candidates in other autoimmune diseases, including celiac disease and lupus. We are proud to be part of the T1D ecosystem and are committed to bringing awareness to the importance and urgency of screening people with a family history of T1D for early-stage disease. Visit ProventionBio.com for more information or follow us on Twitter: @ProventionBio.
SafetyIsThePoint helps people understand how to dispose of used household sharps safely, no matter where they live, work or travel in the United States. The site has a ZIP code locator and free resources about safe sharps disposal. It is a free public education campaign supported by a coalition of leading biopharmaceutical and medical device manufacturers: BD, Biogen, Dexcom, Eli Lilly and Company, Roche, and Sanofi US. Visit SafetyIsThePoint.org.
T1D Exchange is a nonprofit organization that drives improved outcomes in the treatment of type 1 diabetes (T1D). Through quality improvement and collaboration, we harness data and insights to advance T1D research, identify unmet needs in diabetes care, refine best practices and ultimately improve the quality of life for all people living with T1D. The T1D Exchange Registry is a long-term research study open to adults and children with T1D living in the United States. The Registry aims to show how people with T1D are currently doing and how aspects of T1D care and management change over time. Participants complete a questionnaire once per year and can participate in other optional T1D research studies through their Registry Dashboard.
At 10 years old Elizabeth Forrest was diagnosed with type 1 diabetes and soon after declared diabetes wasn’t going to control her. Inspired by her middle school dance class, she combined her love for dance with her new diagnosis and created Dancing for Diabetes® as a way to bring attention to the millions who are living with Type 1 Diabetes and to raise funds to find a cure. Dancing for Diabetes® became a springboard for additional impactful programs that now make up the Touched by Type 1 organization which include: Dancing for Diabetes®, Kids & Teens with Diabetes Dance program, Type 1 @ School, Touched by Type 1 Annual Conference, Outreach, and the D-Box. Until a cure is found, Touched by Type 1 will continue to elevate awareness of Type 1 Diabetes, raise funds to find a cure, and inspire those with diabetes to thrive.